Information Library

Results for: High-quality studies - Product Development & Commercialization - Central Laboratories

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Quintiles Addresses Key Considerations for Successful Biosimilar Development

    Press Release — September 29, 2011 – Regulatory and commercial considerations are the primary drivers for successful biosimilar development, according to a new report from Quintiles.

  • The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer

    White Paper — June 23, 2011
    In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance.

  • Quintiles and Population Genetics Technologies Partner

    Press Release — May 16, 2011 – Quintiles, and Population Genetics Technologies Ltd. (PGT), announced a commercial collaboration to bring genomic testing into mainstream drug development in order to produce safer, more effective medicines.

  • Dr. Frank Massam

    Hear from the Experts — May 13, 2011
    Dr. Frank Massam discusses the significance of Quintiles' partnership with Population Genetics Technologies Ltd.

  • The Importance of Latin America

    Video — June 8, 2009
    Video showing why Latin America’s a great option for Clinical trials. With a total population over 500 million people and only two major languages, you will find a world of opportunity in the region.

  • India Today: Quintiles Central Laboratory

    Video — June 8, 2009
    Video explaining why India’s a great option for clinical trials. Benefits include access to patients, potential cost savings, experienced investigators, and state of the art technology.

  • QUINTILES ADVANCES CANCER TREATMENT THROUGH NEW GENETIC TESTS

    Press Release — May 26, 2009 – Targeted Molecular Diagnostics (TMD), a Quintiles Central Laboratory, announces the availability of two new laboratory tests used to develop more effective cancer treatments.

Page 1 of 1 (7 results)

Subscribe to Email Based on Your Interests

Set preferences